Evidence map›Paper›PMID 21527775›Full record

ArticleAmerican journal of respiratory cell and molecular biology2011

PTEN limits alveolar macrophage function against Pseudomonas aeruginosa after bone marrow transplantation.

Leah L N Hubbard, Carol A Wilke, Eric S White, Bethany B Moore

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Prostaglandin EPharmacology & therapeutics · 2018
    Review
  10. Article
  11. Elevated prostaglandin EMucosal immunology · 2018
    Article
  12. PTEN Inhibition in Human Disease Therapy.Molecules (Basel, Switzerland) · 2018
    Review
  13. Article
  14. Article
  15. Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.American journal of physiology. Lung cellular and molecular physiology · 2014
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Leah L N HubbardDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, USA. bmoore@umich.edu
Carol A Wilke
Eric S White
Bethany B Moore
Pulmonary and Critical Care Associates · USInstitute of Immunology · HR

Funding

RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
PGE2 Regulation of Host Defense post-BMTR01AI065543 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2007 to 2011
$1.9M
Role of EIIIA fibronectin in pulmonary fibrosisR01HL085083 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WHITE, ERIC S · 2007 to 2011
$1.9M
HSCT-induced changes that impair lung innate immunityR56AI065543 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2012 to 2012
$363k
NHLBI NIH HHS HL085083NHLBI NIH HHS L30 HL074723NHLBI NIH HHS R01 HL085083NIAID NIH HHS AI065543NIAID NIH HHS R01 AI065543NIAID NIH HHS R56 AI065543NIAID NIH HHS T32 AI007413
6 · The paper itself

Abstract

Hematopoietic stem cell transplant patients are susceptible to infection despite cellular reconstitution. In a murine model of syngeneic bone marrow transplantation (BMT), we previously reported that BMT mice have impaired host defense against Pseudomonas aeruginosa pneumonia due to overproduction of (PG)E(2) in lung. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is an effector in the PGE(2) signaling pathway that negatively regulates alveolar macrophage (AM) phagocytosis and bacterial killing. Therefore, examined whether overproduction of PGE(2) after BMT inhibits AM host defense by up-regulating PTEN phosphatase activity. We found that PTEN activity is elevated in BMT AMs in response to increased PGE(2) signaling and that pharmacological inhibition of PTEN activity in BMT AMs fully restores phagocytosis of serum-opsonized P. aeruginosa but only partially restores phagocytosis of nonopsonized P. aeruginosa. In wild-type mice transplanted with myeloid-specific conditional PTEN knockout (PTEN CKO) bone marrow, bacterial clearance is improved after challenge with P. aeruginosa pneumonia. Furthermore, PTEN CKO BMT AMs display improved TNF-α production and enhanced phagocytosis and killing of serum-opsonized P. aeruginosa despite overproduction of PGE(2). However, AM phagocytosis of nonopsonized P. aeruginosa is only partially restored in the absence of PTEN after BMT. This may be related to elevated AM expression of IL-1 receptor-associated kinase (IRAK)-M, a molecule previously identified in the PGE(2) signaling pathway to inhibit AM phagocytosis of nonopsonized bacteria. These data suggest that PGE(2) signaling up-regulates IRAK-M independently of PTEN and that these molecules differentially inhibit opsonized and nonopsonized phagocytosis of P. aeruginosa.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalBone Marrow TransplantationDinoprostoneEnzyme InhibitorsIndomethacinInterleukin-1 Receptor-Associated KinasesMacrophages, AlveolarMiceMice, Inbred C57BLMice, KnockoutNeutrophilsOrganometallic CompoundsPhagocytosisPneumonia, BacterialPseudomonas aeruginosaAnti-Inflammatory Agents, Non-SteroidalDinoprostoneEnzyme InhibitorsIndomethacinInterleukin-1 Receptor-Associated KinasesOrganometallic Compoundsoxodiperoxo(pyridine-2-carboxylate)vanadate(V)PTEN PhosphohydrolasePten protein, mouseTumor Necrosis Factor-alpha

Identifiers

PMID21527775
PMCPMC3361361
OpenAlexW2016297875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.